SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Suraksha Diagnostic informs about resignation of CFO and KMP

17 Feb 2025 Evaluate
In continuation to enclosed letter dated 16 January 2025 and in compliance with Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Suraksha Diagnostic has informed that Amit Saraf, Chief Financial Officer (CFO) and Key Managerial Personal (KMP) of the Company has resigned from the closure of business hours of 15 February 2025.

The above information is a part of company’s filings submitted to BSE.


Suraksha Diagnostic Share Price

276.80 15.65 (5.99%)
10-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×